By |

Profile

Mylan is one of the world's largest generic pharmaceutical manufacturers with operations in the United States, Europe, Asia, Middle East, Africa, and Australia. Generic drug sales constitute approximately 90% of revenue. Remaining sales come from a handful of branded products, primarily epinephrine injector EpiPen. Mylan also owns Matrix, an Indian active pharmaceutical ingredient manufacturer.

Contact Information

Website: www.mylan.com
Email: InvestorRelations@mylan.com
Main Phone: +44 1707853000
Address: Building 4, Trident Place
Address 2: Mosquito Way
State: Hertfordshire
City / Town: Hatfield
Country: GBR
Postal Code: AL10 9UL

Issuer Information

Exchange: NGS
CEO: Heather Bresch
Employees: 35000
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Mylan is one of the world's largest generic pharmaceutical manufacturers with operations in the United States, Europe, Asia, Middle East, Africa, and Australia. Generic drug sales constitute approximately 90% of revenue. Remaining sales come from a handful of branded products, primarily epinephrine injector EpiPen. Mylan also owns Matrix, an Indian active pharmaceutical ingredient manufacturer.

Contact Information

Website: www.mylan.com
Email: InvestorRelations@mylan.com
Main Phone: +44 1707853000
Address: Building 4, Trident Place
Address 2: Mosquito Way
State: Hertfordshire
City / Town: Hatfield
Country: GBR
Postal Code: AL10 9UL

Issuer Information

Exchange: NGS
CEO: Heather Bresch
Employees: 35000
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 19.64 $ -0.57 (-2.82%)
Last Price 19.64 Change $ -0.57 Change % -2.82 Tick N/A
Bid 19.68 Bid Size 2,400.00 Ask 19.82 Ask Size 2,000.00
Open 20.04 High 20.07 Low 19.63 Prev Close 20.21
Last Trade Volume 5.4 mi 52 Wk Hi 42.50 52 Wk Low 19.40
Market Cap 10.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 515,437,080.00 EPS (TTM) 0.46 PE Ratio 42.70 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 76
Number of Buys 0 37
Number of Sells 0 39
Net Activity 0 -182124
Last 10 Buys Shares
Joseph C. Maroon 1,000
Joseph C. Maroon 1,000
Robert Cindrich 1,000
Melina E. Higgins 1,000
Melina E. Higgins 1,000
Melina E. Higgins 1,000
Joseph C. Maroon 1,000
Mark W. Parrish 1,000
Wendy Cameron 1,000
Robert Cindrich 1,000
Last 10 Sell Shares
Paul B. Campbell 1,000
Robert J. Coury 1,000
Anthony Mauro 1,000
Rajiv Malik 1,000
Robert J. Coury 1,000
Heather Bresch 1,000
Heather Bresch 1,000
Rajiv Malik 1,000
Anthony Mauro 1,000
Heather Bresch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 59 59 59 59
Low Target Price Estimate 36 36 36 37
Mean Target Price Estimate 48.07 48.2 48.27 48.2
Standard Deviation 7.29 7.17 7.12 7.07
Date of Most Recent Estimate 06/01/18 05/29/18 05/22/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 10 10 9
Moderate Buy 1 1 1 1
Hold 6 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.78 1.74 1.74 1.85